Buckinghamshire, United Kingdom

Paul Harper

This inventor holds 2 USPTO granted patents. Top assignee: Btg International Limited. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Harper. Retrieved from https://idiyas.com/inventor/paul-harper

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Harper: Innovator in Therapeutic Microfoam Technology

Introduction

Paul Harper is a notable inventor based in Buckinghamshire, GB. He has made significant contributions to the field of medical technology, particularly in the development of therapeutic microfoam. With a total of 2 patents to his name, Harper's work is paving the way for advancements in sclerotherapy.

Latest Patents

Harper's latest patents focus on the generation of therapeutic microfoam. The first patent describes a method for producing a microfoam suitable for use in scleropathy of blood vessels. This method involves introducing a physiologically acceptable blood-dispersible gas into a container holding an aqueous sclerosant liquid. Upon releasing the mixture, the components interact to form a microfoam that can be utilized in medical treatments.

Career Highlights

Paul Harper is currently associated with Btg International Limited, where he continues to innovate in the medical technology sector. His work has garnered attention for its potential to improve treatment options for patients suffering from vascular conditions.

Collaborations

Harper has collaborated with notable colleagues, including Anthony David Harman and Neil Pollock. These partnerships have contributed to the development and refinement of his patented technologies.

Conclusion

Paul Harper's contributions to therapeutic microfoam technology represent a significant advancement in medical treatments. His innovative methods and collaborations are set to enhance the effectiveness of sclerotherapy, benefiting countless patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…